566 related articles for article (PubMed ID: 10090061)
1. Genetic galactocerebrosidase deficiency (globoid cell leukodystrophy, Krabbe disease) in rhesus monkeys (Macaca mulatta).
Baskin GB; Ratterree M; Davison BB; Falkenstein KP; Clarke MR; England JD; Vanier MT; Luzi P; Rafi MA; Wenger DA
Lab Anim Sci; 1998 Oct; 48(5):476-82. PubMed ID: 10090061
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate.
Luzi P; Rafi MA; Victoria T; Baskin GB; Wenger DA
Genomics; 1997 Jun; 42(2):319-24. PubMed ID: 9192853
[TBL] [Abstract][Full Text] [Related]
3. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
4. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers.
Victoria T; Rafi MA; Wenger DA
Genomics; 1996 May; 33(3):457-62. PubMed ID: 8661004
[TBL] [Abstract][Full Text] [Related]
5. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger DA; Rafi MA; Luzi P
Hum Mutat; 1997; 10(4):268-79. PubMed ID: 9338580
[TBL] [Abstract][Full Text] [Related]
7. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements.
Shen JS; Watabe K; Ohashi T; Eto Y
Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of globoid cell leukodystrophy in Irish setters.
McGraw RA; Carmichael KP
Vet J; 2006 Mar; 171(2):370-2. PubMed ID: 16490723
[TBL] [Abstract][Full Text] [Related]
10. [Krabbe disease (globoid cell leukodystrophy)].
Sakai N; Inui K; Okada S
Nihon Rinsho; 1995 Dec; 53(12):2947-51. PubMed ID: 8577041
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation.
Luzi P; Rafi MA; Zaka M; Rao HZ; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2005; 86(1-2):150-9. PubMed ID: 16169269
[TBL] [Abstract][Full Text] [Related]
12. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
[TBL] [Abstract][Full Text] [Related]
13. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
[TBL] [Abstract][Full Text] [Related]
14. Clinical signs and neuropathologic abnormalities in working Australian Kelpies with globoid cell leukodystrophy (Krabbe disease).
Fletcher JL; Williamson P; Horan D; Taylor RM
J Am Vet Med Assoc; 2010 Sep; 237(6):682-8. PubMed ID: 20839990
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
16. Serial electrophysiologic studies in rhesus monkeys with Krabbe disease.
Weimer MB; Gutierrez A; Baskin GB; Borda JT; Veazey RS; Myers L; Phillippi-Falkenstein KM; Bunnell BA; Ratterree MS; England JD
Muscle Nerve; 2005 Aug; 32(2):185-90. PubMed ID: 15937878
[TBL] [Abstract][Full Text] [Related]
17. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy.
Lee WC; Tsoi YK; Troendle FJ; DeLucia MW; Ahmed Z; Dicky CA; Dickson DW; Eckman CB
FASEB J; 2007 Aug; 21(10):2520-7. PubMed ID: 17403939
[TBL] [Abstract][Full Text] [Related]
18. Globoid cell leukodystrophy in cairn and West Highland white terriers.
Wenger DA; Victoria T; Rafi MA; Luzi P; Vanier MT; Vite C; Patterson DF; Haskins MH
J Hered; 1999; 90(1):138-42. PubMed ID: 9987921
[TBL] [Abstract][Full Text] [Related]
19. Globoid cell-like leukodystrophy in a domestic longhaired cat.
Sigurdson CJ; Basaraba RJ; Mazzaferro EM; Gould DH
Vet Pathol; 2002 Jul; 39(4):494-6. PubMed ID: 12126153
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment.
Sakai N
Brain Dev; 2009 Aug; 31(7):485-7. PubMed ID: 19332366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
